• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

糖尿病足溃疡局部治疗的文献综述。第2部分：高级治疗方法。

A review of the literature on topical therapies for diabetic foot ulcers. Part 2: Advanced treatments.

作者信息

White R, McIntosh C

机构信息

University of Worcester, UK.

出版信息

J Wound Care. 2009 Aug;18(8):335-41. doi: 10.12968/jowc.2009.18.8.43633.

DOI:10.12968/jowc.2009.18.8.43633
PMID:19862873
Abstract

Following part one, which presented background to diabetic foot ulcers and the principles thought to explain hard-to-heal wounds, part two of this series reviews the efficacy and cost data indicating that certain wound treatments may be of benefit.

摘要

在本系列的第一部分介绍了糖尿病足溃疡的背景以及被认为可解释难愈合伤口的原理之后，本系列的第二部分回顾了疗效和成本数据，这些数据表明某些伤口治疗可能有益。

相似文献

1
A review of the literature on topical therapies for diabetic foot ulcers. Part 2: Advanced treatments.糖尿病足溃疡局部治疗的文献综述。第2部分：高级治疗方法。
J Wound Care. 2009 Aug;18(8):335-41. doi: 10.12968/jowc.2009.18.8.43633.
2
Advanced biological therapies for diabetic foot ulcers.糖尿病足溃疡的先进生物疗法。
Arch Dermatol. 2010 Aug;146(8):857-62. doi: 10.1001/archdermatol.2010.164.
3
The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data.使用贝卡普勒明（Regranex）治疗糖尿病下肢溃疡的成本效益：一个使用瑞典成本数据的核心模型及应用
Value Health. 2000 Nov-Dec;3 Suppl 1:39-46. doi: 10.1046/j.1524-4733.2000.36027.x.
4
Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers.贝卡普勒明治疗难愈性糖尿病神经病变足部溃疡的成本效益
Ostomy Wound Manage. 2003 Nov;49(11):76-84.
5
Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers.重组人血小板衍生生长因子治疗下肢溃疡的临床评估
Plast Reconstr Surg. 2006 Jun;117(7 Suppl):143S-149S; discussion 150S-151S. doi: 10.1097/01.prs.0000222526.21512.4c.
6
Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.伤口护理管理的系统评价：（3）慢性伤口的抗菌剂；（4）糖尿病足溃疡。
Health Technol Assess. 2000;4(21):1-237.
7
Cost-effective management of recalcitrant diabetic foot ulcers.难治性糖尿病足溃疡的经济有效管理
Clin Podiatr Med Surg. 2002 Oct;19(4):483-91. doi: 10.1016/s0891-8422(02)00018-6.
8
Treatment of diabetic foot ulcers using a blood bank platelet concentrate.采用血库血小板浓缩物治疗糖尿病足溃疡。
Plast Reconstr Surg. 2010 Mar;125(3):944-52. doi: 10.1097/PRS.0b013e3181cb6589.
9
Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer.分析重组人血小板衍生生长因子治疗作为糖尿病足溃疡参保患者一线治疗的患者费用。
Adv Skin Wound Care. 2009 Apr;22(4):167-71. doi: 10.1097/01.ASW.0000305466.25177.a8.
10
Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises?生长因子在糖尿病足溃疡治疗中的应用：新技术，有望成功吗？
Int J Low Extrem Wounds. 2007 Mar;6(1):37-53. doi: 10.1177/1534734606298416.

引用本文的文献

1
Designing a Biomaterial Approach to Control the Adaptive Response to a Skin Injury.设计一种生物材料方法来控制对皮肤损伤的适应性反应。
Materials (Basel). 2022 Sep 13;15(18):6366. doi: 10.3390/ma15186366.
2
Consensus on the application of negative pressure wound therapy of diabetic foot wounds.糖尿病足伤口负压伤口治疗应用的共识
Burns Trauma. 2021 Jun 21;9:tkab018. doi: 10.1093/burnst/tkab018. eCollection 2021.
3
[National expert consensus on the application of negative pressure wound therapy in the treatment of diabetic foot wounds (2021 version)].
《负压伤口治疗在糖尿病足创面治疗中应用的全国专家共识（2021版）》
Zhonghua Shao Shang Za Zhi. 2021 Jun 10;37(6):508-518. doi: 10.3760/cma.j.cn.501120-20210107-00010.
4
Elevated Kallikrein-binding protein in diabetes impairs wound healing through inducing macrophage M1 polarization.糖尿病患者中 kallikrein 结合蛋白升高通过诱导巨噬细胞 M1 极化来损害伤口愈合。
Cell Commun Signal. 2019 Jun 10;17(1):60. doi: 10.1186/s12964-019-0376-9.
5
Biomaterial Enhanced Regeneration Design Research for Skin and Load Bearing Applications.用于皮肤和承重应用的生物材料增强再生设计研究
J Funct Biomater. 2019 Jan 26;10(1):10. doi: 10.3390/jfb10010010.
6
Mesenchymal Stem Cells and Transforming Growth Factor-β₃ (TGF-β₃) to Enhance the Regenerative Ability of an Albumin Scaffold in Full Thickness Wound Healing.间充质干细胞与转化生长因子-β₃（TGF-β₃）增强白蛋白支架在全层伤口愈合中的再生能力
J Funct Biomater. 2018 Nov 14;9(4):65. doi: 10.3390/jfb9040065.
7
Oxidized Regenerated Cellulose/Collagen Dressings: Review of Evidence and Recommendations.氧化再生纤维素/胶原蛋白敷料：证据回顾与建议
Adv Skin Wound Care. 2017 Nov;30(11S Suppl 1):S1-S18. doi: 10.1097/01.ASW.0000525951.20270.6c.
8
Normalizing dysfunctional purine metabolism accelerates diabetic wound healing.使功能失调的嘌呤代谢正常化可加速糖尿病伤口愈合。
Wound Repair Regen. 2015 Jan-Feb;23(1):14-21. doi: 10.1111/wrr.12249. Epub 2015 Feb 26.
9
Macrophage stimulating agent soluble yeast β-1,3/1,6-glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo-controlled phase II study.巨噬细胞刺激剂可溶性酵母β-1,3/1,6-葡聚糖作为糖尿病足和腿部溃疡的局部治疗：一项随机、双盲、安慰剂对照的II期研究。
J Diabetes Investig. 2014 Jul;5(4):392-9. doi: 10.1111/jdi.12165. Epub 2013 Dec 2.
10
Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications.基于聚合物的一氧化氮疗法：生物医学应用的最新见解
Adv Funct Mater. 2012 Jan 25;22(2):239-260. doi: 10.1002/adfm.201101707.